Evidence map›Paper›PMID 42317746›Full record

ArticleQatar medical journal2026

Post-COVID-19 anxiety and its impact on adults' health in Qatar in 2022.

Nada Adli, Mohamed Bala, Nahlah AlMesbah, Mai Ajabein, Maysa Homaida, Musa Adli Abuhashem, Nada Mohamad, Tajala Fayyaz, Mishkat Awad, Vahe Kehyayan and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Qatar medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nada AdliCommunity and Preventive Medicine Specialist, Preventive Medicine Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Mohamed BalaCommunity and Preventive Medicine Department, Primary Health Care Corporation (PHCC), Doha, Qatar.
Nahlah AlMesbahCommunity and Preventive Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Mai AjabeinCommunity and Preventive Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Maysa HomaidaCommunity and Preventive Medicine Department, Hamad Medical Corporation, Doha, Qatar.
Musa Adli AbuhashemClinical Psychologist, Psychiatry Department, Hamad Medical Corporation, Doha, Qatar.
Nada MohamadCommunity and Preventive Medicine Specialist, Preventive Medicine Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Tajala FayyazCommunity and Preventive Medicine Specialist, Preventive Medicine Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Mishkat AwadCommunity and Preventive Medicine Specialist, Preventive Medicine Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Vahe KehyayanUniversity of Doha for Science and Technology, Doha, Qatar.
Abdul Hameed Al-KhenjiSenior Consultant of Community and Preventive Medicine, Primary Health Care Corporation (PHCC), Doha, Qatar.
Mohamed Ghaith Al-KuwariSenior Consultant of Community and Preventive Medicine, Primary Health Care Corporation (PHCC), Doha, Qatar.
Iheb BougmizaCommunity and Preventive Medicine Department, Primary Health Care Corporation (PHCC), Doha, Qatar.
Nagah SelimCommunity and Preventive Medicine Department, Primary Health Care Corporation (PHCC), Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Post-COVID-19 syndrome (PCS) is an emerging public health issue characterized by persistent symptoms, including anxiety. Anxiety is the most frequent mental health persistent symptom among patients with PCS, with global prevalence ranging from 6.5% to 63%. It negatively impacts people's functioning, productivity, and daily routine beyond recovery. This study aimed to examine the prevalence, determinants, and health impact of anxiety symptoms among adults with post-COVID-19 in Qatar during 2022. Methods: A cross-sectional study was conducted in Qatar between January and July 2022, utilizing data from the Primary Health Care Corporation's Business Intelligence Unit. Out of 368 eligible individuals, 159 adults with confirmed PCS lasting more than 12 weeks were randomly selected and interviewed by telephone after providing consent. Anxiety levels were assessed using the Generalized Anxiety Disorder-7 (GAD-7) scale. Results: Out of 159, the prevalence of anxiety symptoms was 50.3% ( Conclusion: Post-COVID-19 anxiety is prevalent among PCS patients in Qatar and linked to worse mental and physical health outcomes. Routine screening and integrated care approaches are essential to support recovery.

Indexed as

adultsAnxietypost–COVID-19 syndromeQatar

Identifiers

PMID42317746
PMCPMC13273375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.